Elsevier

Biochemical Pharmacology

Volume 42, Issue 4, 25 July 1991, Pages 947-949
Biochemical Pharmacology

Short communication
Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type

https://doi.org/10.1016/0006-2952(91)90057-CGet rights and content

First page preview

First page preview
Click to open first page preview

References (16)

There are more references available in the full text version of this article.

Cited by (8)

  • Evidence for the catalysis of Dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver

    2000, Toxicology in Vitro
    Citation Excerpt :

    An animal model for CYP2D6 has been sought but with limited success. Neither rat nor mouse forms of CYP2D reflect the human enzyme in terms of in vitro enzyme characterization, or at the primary sequence level (Adams et al., 1991; Boobis et al., 1986; Gonzalez et al., 1987; Kobayashi et al., 1989). There is some evidence that non-human primates have a form of CYP2D which is similar, but clearly not identical to human CYP2D6, as assessed by enzyme kinetic characterization and chemical inhibition studies (Wu et al., 1993).

  • Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes

    1997, Journal of Pharmacology and Experimental Therapeutics
View all citing articles on Scopus

Present address: Addiction Research Foundation, 33 Russell Street, Toronto, Canada.

View full text